Adherence to oral endocrine treatments in women with breast cancer: can it be improved? Sheila A. Doggrell Review 19 May 2011 Pages: 299 - 308
Pregnancy after breast cancer: if you wish, maāam Olivia PaganiAnn PartridgeAron Goldhirsch Review 23 June 2011 Pages: 309 - 317
Molecular classification of breast phyllodes tumors: validation of the histologic grading scheme and insights into malignant progression Mei Kim AngAik Seng OoiPuay Hoon Tan Preclinical study 14 October 2010 Pages: 319 - 329
Crosstalk between nicotine and estrogen-induced estrogen receptor activation induces Ī±9-nicotinic acetylcholine receptor expression in human breast cancer cells Chia-Hwa LeeYa-Chieh ChangYuan-Soon Ho Preclinical study 16 October 2010 Pages: 331 - 345
Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue Sibyll HeinVolkmar MĆ¼llerKarin Milde-Langosch Preclinical study 23 October 2010 Pages: 347 - 360
Ras-related protein 1 and the insulin-like growth factor type I receptor are associated with risk of progression in patients diagnosed with carcinoma in situ Dana K. FurstenauNandita MitraMarina A. Guvakova Preclinical study 26 October 2010 Pages: 361 - 372
Expression of Abl interactor 1 and its prognostic significance in breast cancer: a tissue-array-based investigation Chunjie WangDanh Tran-ThanhSusan J. Done Preclinical study 03 November 2010 Pages: 373 - 386
The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells Caroline BrĆ¼nner-KubathWaheed ShabbirThomas W. Grunt Preclinical study 03 November 2010 Pages: 387 - 400
Economic issues involved in integrating genomic testing into clinical care: the case of genomic testing to guide decision-making about chemotherapy for breast cancer patients Patricia MarinoCarole SianiValƩrie Seror Preclinical study 09 November 2010 Pages: 401 - 409
Inhibition of the c-fms proto-oncogene autocrine loop and tumor phenotype in glucocorticoid stimulated human breast carcinoma cells Eugene P. ToyTiffany LambSetsuko K. Chambers Preclinical Study 10 November 2010 Pages: 411 - 419
Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features Gulnur GulerCigdem HimmetogluKay Huebner Preclinical study 11 November 2010 Pages: 421 - 432
Nuclear co-localization and functional interaction of COX-2 and HIF-1Ī± characterize bone metastasis of human breast carcinoma Paola MaroniEmanuela MatteucciMaria Alfonsina Desiderio Preclinical study 11 November 2010 Pages: 433 - 450
Artificial neural network analysis of circulating tumor cells in metastatic breast cancer patients Antonio GiordanoMario GiulianoJames M. Reuben Clinical trial 28 June 2011 Pages: 451 - 458
Surgery of the primary tumor does not improve survival in stage IV breast cancer Laura DominiciJulie NajitaMehra Golshan Clinical Trial 29 June 2011 Pages: 459 - 465
A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancer C. K. LeeM. HudsonR. J. Simes Epidemiology 29 March 2011 Pages: 467 - 476
Bulky DNA adducts and breast cancer risk in the prospective EPIC-Italy study Calogero SaievaMarco PelusoDomenico Palli Epidemiology 31 March 2011 Pages: 477 - 484
Dietary fiber is associated with circulating concentrations of C-reactive protein in breast cancer survivors: the HEAL study Adriana VillaseƱorAnita AmbsMarian L. Neuhouser Epidemiology 01 April 2011 Pages: 485 - 494
Survival in breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1999ā2007) Mellissa YongAnnette Ćstergaard JensenHenrik Toft SĆørensen Epidemiology 02 April 2011 Pages: 495 - 503
Adipose levels of polybrominated diphenyl ethers and risk of breast cancer Susan HurleyPeggy ReynoldsMyrto Petreas Epidemiology 06 April 2011 Pages: 505 - 511
TNF-alpha polymorphisms and breast cancer Yu YangRennan FengYuqing Xu Epidemiology 08 April 2011 Pages: 513 - 519
Associations of physical activity with quality of life and functional ability in breast cancer patients during active adjuvant treatment: the Pathways Study Jeanne S. MandelblattGheorghe LutaLawrence H. Kushi Epidemiology 08 April 2011 Pages: 521 - 529
Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States Martha L. SlatteryKathy B. BaumgartnerRoger K. Wolff Epidemiology 08 April 2011 Pages: 531 - 539
The use of atypical antipsychotics and the risk of breast cancer Laurent AzoulayHui YinSamy Suissa Epidemiology 09 April 2011 Pages: 541 - 548
Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort Patricia A. GanzLaurel A. HabelSteven W. Cole Epidemiology 11 April 2011 Pages: 549 - 556
Cancer risk in Jewish BRCA1 and BRCA2 mutation carriers: Effects of oral contraceptive use and parental origin of mutation Shiri BernholtzYael LaitmanEitan Friedman Epidemiology 16 April 2011 Pages: 557 - 563
Obesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study Shannon M. ConroyGertraud MaskarinecLaurence N. Kolonel Epidemiology 16 April 2011 Pages: 565 - 574
Androgen receptor polyglutamine tract length in Egyptian male breast cancer patients Samuel F. GilbertAmr S. SolimanSofia D. Merajver Epidemiology 20 April 2011 Pages: 575 - 581
The relationship between bone mineral density and mammographic density in Korean women: The Healthy Twin study Joohon SungYun-Mi SongKayoung Lee Epidemiology 22 April 2011 Pages: 583 - 591
Common genetic variation in adiponectin, leptin, and leptin receptor and association with breast cancer subtypes Sarah J. NyanteMarilie D. GammonRobert C. Millikan Epidemiology 23 April 2011 Pages: 593 - 606
Biologic markers determine both the risk and the timing of recurrence in breast cancer Laura J. EssermanDan H. MooreChristopher C. Benz Brief Report 20 May 2011 Pages: 607 - 616
Evaluation of associations between common variation in mitotic regulatory pathways and risk of overall and high grade breast cancer Kristen N. StevensXianshu WangFergus J. Couch Brief Report 24 May 2011 Pages: 617 - 622
Simultaneous measurement of ERĪ±, HER2, and PhosphoERK1/2 in breast cancer cell lines by flow cytometry Ulas Darda BayraktarTae Kon KimKrishna V. Komanduri Brief Report 24 May 2011 Pages: 623 - 628
Two patients with germline mutations in both BRCA1 and BRCA2 discovered unintentionally: a case series and discussion of BRCA testing modalities Ann Marie AugustynNicole M. AgostinoMartin A. Martino Brief Report 24 May 2011 Pages: 629 - 634
PIK3CA mutations rarely demonstrate genotypic intratumoral heterogeneity and are selected for in breast cancer progression Kevin KalinskyAdriana HeguyMary Ellen Moynahan Brief Report 27 May 2011 Pages: 635 - 643
Association between two polymorphisms of CD166/ALCAM gene and breast cancer risk in Chinese women Qinglong LiFeng Xu Letter to the Editor 22 April 2011 Pages: 645 - 647
Need for clarification of data in the recent meta-analysis about RAD51 135G>C polymorphism and breast cancer risk Xiao-Feng HeJiao SuYi Liu Letter to the Editor 03 May 2011 Pages: 649 - 653
Association of XPC polymorphisms with breast cancer risk Feng XuDewu ZhongYu Zhu Letter to the Editor 08 May 2011 Pages: 655 - 657